CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 7, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2016-09-05
DOI
10.3389/fphar.2016.00275
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The effects of ivacaftor on CF fatty acid metabolism: An analysis from the GOAL study
- (2017) Michael Glenn O'Connor et al. Journal of Cystic Fibrosis
- Augmentation of CFTR maturation by S-nitrosoglutathione reductase
- (2016) Khalequz Zaman et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770
- (2016) Martina Gentzsch et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Sources of Variation in Sweat Chloride Measurements in Cystic Fibrosis
- (2016) Joseph M. Collaco et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations
- (2016) Venkateshwar Mutyam et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Low free drug concentration prevents inhibition of F508del CFTR functional expression by the potentiator VX-770 (ivacaftor)
- (2016) Elizabeth Matthes et al. BRITISH JOURNAL OF PHARMACOLOGY
- A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR
- (2016) A Tosco et al. CELL DEATH AND DIFFERENTIATION
- Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screening
- (2016) Ivana Pibiri et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- β2-Adrenergic receptor agonists activate CFTR in intestinal organoids and subjects with cystic fibrosis
- (2016) Lodewijk A.W. Vijftigschild et al. EUROPEAN RESPIRATORY JOURNAL
- Optimal correction of distinct CFTR folding mutants in rectal cystic fibrosis organoids
- (2016) Johanna F. Dekkers et al. EUROPEAN RESPIRATORY JOURNAL
- A synonymous codon change alters the drug sensitivity of ΔF508 cystic fibrosis transmembrane conductance regulator
- (2016) Vedrana Bali et al. FASEB JOURNAL
- Cystic fibrosis newborn screening programs: implications of the CFTR variant spectrum in nonwhite patients
- (2016) Lynn Pique et al. GENETICS IN MEDICINE
- EPAC1 activation by cAMP stabilizes CFTR at the membrane by promoting its interaction with NHERF1
- (2016) Miguel J. Lobo et al. JOURNAL OF CELL SCIENCE
- Acidic pH increases airway surface liquid viscosity in cystic fibrosis
- (2016) Xiao Xiao Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Limited premature termination codon suppression by read-through agents in cystic fibrosis intestinal organoids
- (2016) D.D. Zomer-van Ommen et al. Journal of Cystic Fibrosis
- Potentiator synergy in rectal organoids carrying S1251N, G551D, or F508del CFTR mutations
- (2016) Johanna F. Dekkers et al. Journal of Cystic Fibrosis
- Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic Fibrosis
- (2016) Grazyna Faure et al. JOURNAL OF MOLECULAR BIOLOGY
- The Spectrum of CFTR Variants in Nonwhite Cystic Fibrosis Patients
- (2016) Iris Schrijver et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator
- (2016) Ying-Chun Yu et al. JOURNAL OF PHYSIOLOGY-LONDON
- From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations
- (2016) Gudio Veit et al. MOLECULAR BIOLOGY OF THE CELL
- CFTR is a tumor suppressor gene in murine and human intestinal cancer
- (2016) B L N Than et al. ONCOGENE
- Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic Fibrosis
- (2016) Vedrana Bali et al. PLoS One
- New and emerging targeted therapies for cystic fibrosis
- (2016) Bradley S Quon et al. BMJ-British Medical Journal
- Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect
- (2016) Guido Veit et al. PLOS BIOLOGY
- New and emerging targeted therapies for cystic fibrosis
- (2016) Bradley S Quon et al. BMJ-British Medical Journal
- Treatment of cystic fibrosis in low-income countries
- (2016) Malena Cohen-Cymberknoh et al. Lancet Respiratory Medicine
- Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study
- (2016) Jane C Davies et al. Lancet Respiratory Medicine
- Newborn screening for cystic fibrosis
- (2016) Carlo Castellani et al. Lancet Respiratory Medicine
- Efficacy and safety of lumacaftor/ivacaftor combination therapy in patients with cystic fibrosis homozygous for Phe508del CFTR by pulmonary function subgroup: a pooled analysis
- (2016) J Stuart Elborn et al. Lancet Respiratory Medicine
- Sustained Benefit from Ivacaftor Demonstrated by Combining Clinical Trial and Cystic Fibrosis Patient Registry Data
- (2015) Gregory S. Sawicki et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Natural Variation in Gene Expression Modulates the Severity of Mutant Phenotypes
- (2015) Victoria Vu et al. CELL
- Regional Isolation Drives Bacterial Diversification within Cystic Fibrosis Lungs
- (2015) Peter Jorth et al. Cell Host & Microbe
- Capturing the Direct Binding of CFTR Correctors to CFTR by Using Click Chemistry
- (2015) Chandrima Sinha et al. CHEMBIOCHEM
- The Role of Ivacaftor in Severe Cystic Fibrosis in a Patient With the R117H Mutation
- (2015) Nicola J. Ronan et al. CHEST
- Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor
- (2015) Drucy Borowitz et al. DIGESTIVE DISEASES AND SCIENCES
- Synthesis and structure–activity relationship of aminoarylthiazole derivatives as correctors of the chloride transport defect in cystic fibrosis
- (2015) Emanuela Pesce et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives
- (2015) Ivana Pibiri et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Future trends in cystic fibrosis demography in 34 European countries
- (2015) Pierre-Régis Burgel et al. EUROPEAN RESPIRATORY JOURNAL
- Cystic fibrosis on the African continent
- (2015) Cheryl Stewart et al. GENETICS IN MEDICINE
- Small-scale high-throughput sequencing–based identification of new therapeutic tools in cystic fibrosis
- (2015) Jennifer Bonini et al. GENETICS IN MEDICINE
- Effect of ivacaftor treatment in patients with cystic fibrosis and the G551D-CFTR mutation: patient-reported outcomes in the STRIVE randomized, controlled trial
- (2015) Alexandra Quittner et al. Health and Quality of Life Outcomes
- Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides
- (2015) Susana Igreja et al. HUMAN MUTATION
- Non-native Conformers of Cystic Fibrosis Transmembrane Conductance Regulator NBD1 Are Recognized by Hsp27 and Conjugated to SUMO-2 for Degradation
- (2015) Xiaoyan Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rescuing Trafficking Mutants of the ATP-binding Cassette Protein, ABCA4, with Small Molecule Correctors as a Treatment for Stargardt Eye Disease
- (2015) Inna Sabirzhanova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combination of Correctors Rescue ΔF508-CFTR by Reducing Its Association with Hsp40 and Hsp27
- (2015) Miquéias Lopes-Pacheco et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis
- (2015) Sandra Pankow et al. NATURE
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) Claire E. Wainwright et al. NEW ENGLAND JOURNAL OF MEDICINE
- Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy
- (2015) Panagiotis Mastorakos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted delivery of liquid microvolumes into the lung
- (2015) Jinho Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanocomplexes for gene therapy of respiratory diseases: Targeting and overcoming the mucus barrier
- (2015) Sante Di Gioia et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- A molecular switch in the scaffold NHERF1 enables misfolded CFTR to evade the peripheral quality control checkpoint
- (2015) Cláudia A. Loureiro et al. Science Signaling
- Oxidation increases mucin polymer cross-links to stiffen airway mucus gels
- (2015) Shaopeng Yuan et al. Science Translational Medicine
- Pediatric Cystic Fibrosis Sputum Can Be Chemically Dynamic, Anoxic, and Extremely Reduced Due to Hydrogen Sulfide Formation
- (2015) Elise S. Cowley et al. mBio
- Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis
- (2015) Harriet Corvol et al. Nature Communications
- Unravelling druggable signalling networks that control F508del-CFTR proteostasis
- (2015) Ramanath Narayana Hegde et al. eLife
- A molecular switch in the scaffold NHERF1 enables misfolded CFTR to evade the peripheral quality control checkpoint
- (2015) Cláudia A. Loureiro et al. Science Signaling
- Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
- (2015) Eric W F W Alton et al. Lancet Respiratory Medicine
- Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial
- (2015) Richard B Moss et al. Lancet Respiratory Medicine
- Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses
- (2015) S. L. LaFayette et al. Science Advances
- Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis
- (2015) Nikhil T. Awatade et al. EBioMedicine
- Rescue of NBD2 Mutants N1303K and S1235R of CFTR by Small-Molecule Correctors and Transcomplementation
- (2015) Daniele Rapino et al. PLoS One
- Pseudomonas aeruginosa Reduces VX-809 Stimulated F508del-CFTR Chloride Secretion by Airway Epithelial Cells
- (2015) Bruce A. Stanton et al. PLoS One
- VIP regulates CFTR membrane expression and function in Calu-3 cells by increasing its interaction with NHERF1 and P-ERM in a VPAC1- and PKCε-dependent manner
- (2014) Walaa Alshafie et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis
- (2014) Steven M. Rowe et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry
- (2014) Todd MacKenzie et al. ANNALS OF INTERNAL MEDICINE
- Stabilizing Rescued Surface-Localized ΔF508 CFTR by Potentiation of Its Interaction with Na+/H+ Exchanger Regulatory Factor 1
- (2014) Kavisha Arora et al. BIOCHEMISTRY
- Roscovitine is a proteostasis regulator that corrects the trafficking defect of F508del-CFTR by a CDK-independent mechanism
- (2014) C Norez et al. BRITISH JOURNAL OF PHARMACOLOGY
- VX-809 and Related Corrector Compounds Exhibit Secondary Activity Stabilizing Active F508del-CFTR after Its Partial Rescue to the Cell Surface
- (2014) Paul D.W. Eckford et al. CHEMISTRY & BIOLOGY
- Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier
- (2014) Jung Soo Suk et al. JOURNAL OF CONTROLLED RELEASE
- Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
- (2014) Kris De Boeck et al. Journal of Cystic Fibrosis
- European Cystic Fibrosis Society Standards of Care: Best Practice guidelines
- (2014) Alan R. Smyth et al. Journal of Cystic Fibrosis
- Multi-Country Estimate of Different Manifestations of Aspergillosis in Cystic Fibrosis
- (2014) Joanne Armstead et al. PLoS One
- Some gating potentiators, including VX-770, diminish F508-CFTR functional expression
- (2014) G. Veit et al. Science Translational Medicine
- Potentiator ivacaftor abrogates pharmacological correction of F508 CFTR in cystic fibrosis
- (2014) D. M. Cholon et al. Science Translational Medicine
- Modulation of the Maladaptive Stress Response to Manage Diseases of Protein Folding
- (2014) Daniela Martino Roth et al. PLOS BIOLOGY
- Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Eitan Kerem et al. Lancet Respiratory Medicine
- A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial
- (2014) Michael P Boyle et al. Lancet Respiratory Medicine
- Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp- CFTR mutation: a phase 3, open-label extension study (PERSIST)
- (2014) Edward F McKone et al. Lancet Respiratory Medicine
- Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with aG551DMutation
- (2013) Jane C. Davies et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Synthetic Aminoglycosides Efficiently Suppress Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations and Are Enhanced by Ivacaftor
- (2013) Xiaojiao Xue et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Disease-relevant proteostasis regulation of cystic fibrosis transmembrane conductance regulator
- (2013) V R Villella et al. CELL DEATH AND DIFFERENTIATION
- Rescuing Mutant CFTR: A Multi-task Approach to a Better Outcome in Treating Cystic Fibrosis
- (2013) Margarida D. Amaral et al. CURRENT PHARMACEUTICAL DESIGN
- The silent codon change I507-ATC→ATT contributes to the severity of the ΔF508 CFTR channel dysfunction
- (2013) Ahmed Lazrak et al. FASEB JOURNAL
- Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
- (2013) E W F W Alton et al. GENE THERAPY
- Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research
- (2013) Naihua Duan et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Sweat chloride as a biomarker of CFTR activity: Proof of concept and ivacaftor clinical trial data
- (2013) Frank J. Accurso et al. Journal of Cystic Fibrosis
- Effect of ivacaftor on CFTR forms with missense mutations associated with defects in protein processing or function
- (2013) Fredrick Van Goor et al. Journal of Cystic Fibrosis
- Premature Termination Codon Read-Through in the ABCC6 Gene: Potential Treatment for Pseudoxanthoma Elasticum
- (2013) Yong Zhou et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- COPII machinery cooperates with ER-localized Hsp40 to sequester misfolded membrane proteins into ER-associated compartments
- (2013) Shogo Kakoi et al. MOLECULAR BIOLOGY OF THE CELL
- Mechanism-based corrector combination restores ΔF508-CFTR folding and function
- (2013) Tsukasa Okiyoneda et al. Nature Chemical Biology
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
- (2013) Patrick R Sosnay et al. NATURE GENETICS
- Compounds that correct F508del-CFTR trafficking can also correct other protein trafficking diseases: an in vitro study using cell lines
- (2013) Heidi M Sampson et al. Orphanet Journal of Rare Diseases
- Insulin secretion improves in cystic fibrosis following ivacaftor correction of CFTR: a small pilot study
- (2013) Melena D Bellin et al. PEDIATRIC DIABETES
- Ubiquitination and Degradation of CFTR by the E3 Ubiquitin Ligase MARCH2 through Its Association with Adaptor Proteins CAL and STX6
- (2013) Jie Cheng et al. PLoS One
- Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules
- (2013) O. M. Woodward et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D- CFTR mutation and preserved spirometry: a randomised controlled trial
- (2013) Jane Davies et al. Lancet Respiratory Medicine
- Management of comorbidities in older patients with cystic fibrosis
- (2013) Barry J Plant et al. Lancet Respiratory Medicine
- HGF Stimulation of Rac1 Signaling Enhances Pharmacological Correction of the Most Prevalent Cystic Fibrosis Mutant F508del-CFTR
- (2012) Sónia Moniz et al. ACS Chemical Biology
- Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator
- (2012) Alessandro Luciani et al. Autophagy
- Requirements for Efficient Correction of ΔF508 CFTR Revealed by Analyses of Evolved Sequences
- (2012) Juan L. Mendoza et al. CELL
- Correctors of ΔF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein
- (2012) Lihua He et al. FASEB JOURNAL
- Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator VX-770 (Ivacaftor) Opens the Defective Channel Gate of Mutant CFTR in a Phosphorylation-dependent but ATP-independent Manner
- (2012) Paul D. W. Eckford et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Ivacaftor potentiation of multiple CFTR channels with gating mutations
- (2012) Haihui Yu et al. Journal of Cystic Fibrosis
- Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype
- (2012) Jenny K. Gustafsson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer Risk in Cystic Fibrosis: A 20-Year Nationwide Study From the United States
- (2012) Patrick Maisonneuve et al. JNCI-Journal of the National Cancer Institute
- Small heat shock proteins target mutant cystic fibrosis transmembrane conductance regulator for degradation via a small ubiquitin-like modifier–dependent pathway
- (2012) Annette Ahner et al. MOLECULAR BIOLOGY OF THE CELL
- The impact of newborn screening and earlier intervention on the clinical course of cystic fibrosis
- (2012) F. Nicole Dijk et al. Paediatric Respiratory Reviews
- A Chaperone Trap Contributes to the Onset of Cystic Fibrosis
- (2012) Judith A. Coppinger et al. PLoS One
- Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies
- (2012) Michael Wilschanski et al. Drug Design Development and Therapy
- Ouabain Mimics Low Temperature Rescue of F508del-CFTR in Cystic Fibrosis Epithelial Cells
- (2012) Donglei Zhang et al. Frontiers in Pharmacology
- Managing Cystic Fibrosis
- (2011) Malena Cohen-Cymberknoh et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Identification of a NBD1-Binding Pharmacological Chaperone that Corrects the Trafficking Defect of F508del-CFTR
- (2011) Heidi M. Sampson et al. CHEMISTRY & BIOLOGY
- Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
- (2011) M. Wilschanski et al. EUROPEAN RESPIRATORY JOURNAL
- Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study
- (2011) D. Bilton et al. EUROPEAN RESPIRATORY JOURNAL
- Dual Activity of Aminoarylthiazoles on the Trafficking and Gating Defects of the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Caused by Cystic Fibrosis Mutations
- (2011) Nicoletta Pedemonte et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Guideline on the design and conduct of cystic fibrosis clinical trials: The European Cystic Fibrosis Society–Clinical Trials Network (ECFS-CTN)
- (2011) K. De Boeck et al. Journal of Cystic Fibrosis
- Curcumin and genistein additively potentiate G551D-CFTR
- (2011) Ying-Chun Yu et al. Journal of Cystic Fibrosis
- Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54
- (2011) Steven M. Rowe et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutation
- (2011) Bonnie W. Ramsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human cystic fibrosis airway epithelia have reduced Cl- conductance but not increased Na+ conductance
- (2011) O. A. Itani et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
- (2011) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for theF508del-CFTRmutation
- (2011) J P Clancy et al. THORAX
- CFTR: folding, misfolding and correcting the ΔF508 conformational defect
- (2011) Gergely L. Lukacs et al. TRENDS IN MOLECULAR MEDICINE
- Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
- (2010) Isabelle Sermet-Gaudelus et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Loss of Anion Transport without Increased Sodium Absorption Characterizes Newborn Porcine Cystic Fibrosis Airway Epithelia
- (2010) Jeng-Haur Chen et al. CELL
- The Cystic Fibrosis Transmembrane Conductance Regulator Impedes Proteolytic Stimulation of the Epithelial Na+Channel
- (2010) Martina Gentzsch et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations
- (2010) Deborah R. Zucker et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Upper and lower airway cultures in children with cystic fibrosis: Do not neglect the upper airways
- (2010) Hilde J.C. Bonestroo et al. Journal of Cystic Fibrosis
- Syntaxin 6 and CAL Mediate the Degradation of the Cystic Fibrosis Transmembrane Conductance Regulator
- (2010) Jie Cheng et al. MOLECULAR BIOLOGY OF THE CELL
- Biological and Structural Basis for Aha1 Regulation of Hsp90 ATPase Activity in Maintaining Proteostasis in the Human Disease Cystic Fibrosis
- (2010) Atanas V. Koulov et al. MOLECULAR BIOLOGY OF THE CELL
- Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition
- (2010) Alessandro Luciani et al. NATURE CELL BIOLOGY
- Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTRMutation
- (2010) Frank J. Accurso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hsp 70/Hsp 90 organizing protein as a nitrosylation target in cystic fibrosis therapy
- (2010) N. V. Marozkina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane
- (2010) T. Okiyoneda et al. SCIENCE
- Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis
- (2010) A. Prayle et al. THORAX
- Emergent Properties of Proteostasis in Managing Cystic Fibrosis
- (2010) W. E. Balch et al. Cold Spring Harbor Perspectives in Biology
- Development of PEGylated PLGA nanoparticle for controlled and sustained drug delivery in cystic fibrosis
- (2010) Neeraj Vij et al. JOURNAL OF NANOBIOTECHNOLOGY
- Activation of the Cystic Fibrosis Transmembrane Conductance Regulator by the Flavonoid Quercetin
- (2009) Louise C. Pyle et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic
- (2009) Rina Glozman et al. JOURNAL OF CELL BIOLOGY
- Rescue of Functional F508del Cystic Fibrosis Transmembrane Conductance Regulator by Vasoactive Intestinal Peptide in the Human Nasal Epithelial Cell Line JME/CF15
- (2009) S. Rafferty et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Na+/H+ Exchanger Regulatory Factor 1 Overexpression-dependent Increase of Cytoskeleton Organization Is Fundamental in the Rescue of F508del Cystic Fibrosis Transmembrane Conductance Regulator in Human Airway CFBE41o- Cells
- (2009) Maria Favia et al. MOLECULAR BIOLOGY OF THE CELL
- Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
- (2009) Darren M Hutt et al. Nature Chemical Biology
- Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770
- (2009) F. Van Goor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutational analysis of ABC proteins
- (2008) Tip W. Loo et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Role of calnexin in the ER quality control and productive folding of CFTR; differential effect of calnexin knockout on wild-type and ΔF508 CFTR
- (2008) Tsukasa Okiyoneda et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders
- (2008) Samuel M Moskowitz et al. GENETICS IN MEDICINE
- Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report
- (2008) Philip M. Farrell et al. JOURNAL OF PEDIATRICS
- Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
- (2008) Eitan Kerem et al. LANCET
- Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function
- (2008) A. W. R. Serohijos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search